tradmap

SYK Financials Stryker Corporation

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 11.8% per year over the past 5 years.
  • Net income has grown faster than revenue (15.2% vs 11.8% per year).
  • Operating margin has expanded, at 19.5% in the latest year.
  • Free cash flow has grown 9.0% per year over the past 5 years.

Financial health

  • Total debt ($15.9B) exceeds cash ($4.0B); net debt is $11.8B.
  • Total debt has grown slower than revenue (2.5% vs 11.8% per year).
  • Operating income covered interest expense 8.1× in the latest year.
  • Total debt is 2.5× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 39.6% of earnings and 30.0% of free cash flow.
  • The dividend has grown 8.3% per year over the past 5 years.
Revenue & net income
$0 $13B $25B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 33% 66% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $2B $4B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $8B $16B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$5B $89M $5B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $25.1B $3.2B 64.0% 19.5% $4.3B $15.9B $4.0B
2024 $22.6B $3.0B 63.9% 16.3% $3.5B $13.6B $3.7B
2023 $20.5B $3.2B 63.7% 19.0% $3.1B $13.0B $3.0B
2022 $18.4B $2.4B 62.8% 15.4% $2.0B $13.0B $1.8B
2021 $17.1B $2.0B 64.1% 15.1% $2.7B $12.5B $2.9B
2020 $14.4B $1.6B 63.1% 15.5% $2.8B $14.0B $2.9B
2019 $14.9B $2.1B 65.1% 18.2% $1.5B $11.1B $4.3B
2018 $13.6B $3.6B 65.7% 18.7% $2.0B $9.9B $3.6B
2017 $12.4B $1.0B 65.7% 18.5% $961M $7.2B $2.5B
2016 $11.3B $1.6B 66.3% 19.2% $1.4B $6.9B $3.3B
2015 $1.4B $711M $4.0B $3.4B
2014 $515M $1.5B $4.0B $1.8B
2013 $1.0B $1.7B $2.8B $1.3B
2012 $1.3B $1.4B $1.8B $1.4B
2011 $1.3B $1.2B $1.8B $905M

Valuation over time

How the market has priced SYK against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 25.3 50.6 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 3.7 7.3 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 0.5 1.1 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is SYK growing its revenue and profit?

Over the past 5 years, Stryker Corporation's revenue has grown 11.8% per year, and net income grown 15.2% per year. These are computed facts, not advice.

How much debt does SYK have?

As of FY2025, Stryker Corporation reported $15.9B of total debt against $4.0B of cash; operating income covered interest expense 8.1×.

What is SYK's profit margin?

In FY2025, gross margin was 64.0%, operating margin 19.5%, and net margin 12.9%.

What is SYK's P/E ratio?

As of Jun '26, Stryker Corporation traded at a price-to-earnings ratio of about 37.3× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.